Serial exposure to ethanol drinking and methamphetamine enhances glutamate excitotoxicity by Blaker, Amanda L. et al.
A
cc
ep
te
d 
A
rt
ic
le
MS. AMANDA L. BLAKER (Orcid ID : 0000-0003-4177-0223) 
 
Article type      : Original Article 
 
Serial exposure to ethanol drinking and methamphetamine enhances glutamate 
excitotoxicity. 
 
Amanda L. Blaker 
University of Toledo College of Medicine 
Department of Neurosciences 
3000 Arlington Avenue 
Toledo, OH 43614 
 
Elizabeth R. Moore 
Indiana University School of Medicine 
Department of Pharmacology & Toxicology 
635 Barnhill Drive 
Indianapolis, IN 46202 
 
____________________________________________________
This is the author's manuscript of the article published in final edited form as: 
Blaker, A. L., Moore, E. R., & Yamamoto, B. K. (2019). Serial exposure to ethanol drinking and methamphetamine enhances 
glutamate excitotoxicity. Journal of Neurochemistry, 0(ja). https://doi.org/10.1111/jnc.14861
A
cc
ep
te
d 
A
rt
ic
le
This article is protected by copyright. All rights reserved. 
Bryan K. Yamamoto# 
Indiana University School of Medicine 
Department of Pharmacology & Toxicology 
635 Barnhill Drive, MS A418  
Indianapolis, IN 46202 
 
#Corresponding author at: Department of Pharmacology & Toxicology, 635 Barnhill Drive, 
MS A418, Indianapolis, IN 46202, brkyama@iu.edu 
 
Abstract 
A significant comorbidity exists between alcohol and methamphetamine (Meth) abuse but 
the neurochemical consequences of this co-abuse are unknown. Alcohol and Meth 
independently and differentially affect glutamatergic transmission but the unique effects of 
their serial exposure on glutamate signaling in mediating damage to dopamine neurons are 
unknown.  Sprague Dawley rats had intermittent voluntary access to 10% ethanol (EtOH) 
every other day and water over 28 days and were then administered a binge injection 
regimen of Meth or saline.  EtOH drinking decreased the glutamate aspartate transporter 
(GLAST) and increased basal extracellular concentrations of glutamate within the striatum 
when measured after the last day of drinking. Ceftriaxone is known to increase the 
expression and/or activity of glutamate transporters in the brain and prevented both the 
decreases in GLAST and the increases in basal extracellular glutamate when administered 
during EtOH drinking.  EtOH drinking also exacerbated the acute increases in extracellular 
glutamate observed upon Meth exposure, the subsequent increases in spectrin proteolysis, 
and the long-term decreases in dopamine content in the striatum, all of which were 
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attenuated by ceftriaxone administration during EtOH drinking only. These results implicate 
EtOH-induced increases in extracellular glutamate and corresponding decreases in 
glutamate uptake as mechanisms that contribute to the vulnerability produced by EtOH 
drinking and the unique neurotoxicity observed after serial exposure to Meth that is not 
observed with either drug alone.  
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Abbreviations 
1. aCSF……………………………………Artificial cerebrospinal fluid 
2. CamKII………………………………….Calcium-calmodulin-dependent protein 
kinase II 
3. CEF……………………………………...Ceftriaxone 
4. COX-2…………………………………..Cyclooxygenase-2 
5. EAAT1/2………………...………………Excitatory amino acid transporter ½ 
6. EtOH……………………………………..Ethanol 
7. GLAST…………………………………..Glutamate aspartate transporter 
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8. GLT-1……………………………………Glutamate transporter 1 
9. LPS………………………………………Lipopolysaccharide 
10. Meth……………………………………...Methamphetamine 
11. NMDA…………………………………… N-methyl-D-aspartate 
12. OPA…………………………………….. o-pthaldialdehyde 
13. RRID……………………………………..Research Resource Identifier (see 
scicrunch.org) 
14. SBP………………………………………Spectrin breakdown product 
 
Introduction 
Alcohol and methamphetamine (Meth) are commonly co-abused and act on similar 
neurotransmitter systems. Abuse of these drugs is a significant problem highlighted by a 
recent study from the National Epidemiologic Survey on Alcohol and Related Conditions 
reporting that alcohol use, high-risk drinking, and DSM V-diagnosed alcohol use disorders 
have all increased in the United States (Grant et al. 2017). Furthermore, abuse of alcohol 
and Meth is a prevalent comorbidity amongst Meth users (Stinson et al. 2005; Bujarski et al. 
2014; Leslie et al. 2017), but the causes and consequences of their co-abuse have only 
been recently examined (Fultz et al. 2017) and remain undefined.  
 
A mechanism underlying the toxic effects of alcohol includes inflammation derived from the 
gastrointestinal (GI) tract, liver, and brain (Massey & Arteel 2012; Bishehsari et al. 2017; 
Leclercq et al. 2017; Vallés et al. 2004; Wang et al. 2010) whereas the neurotoxic effects of 
Meth are mediated by neuroinflammation and excitotoxicity (Mark et al. 2004; Battaglia et al. 
2002; Stephans & Yamamoto 1994; Thomas & Kuhn 2005). Enhanced dopamine toxicity 
has been observed after the serial exposure to alcohol and Meth in the striatum that may be 
mediated by neuroinflammation via increases in cyclooxygenase-2 (COX-2) from alcohol 
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drinking (Blaker & Yamamoto, 2018) but this requires further investigation.  Although 
neuroinflammation can promote glutamate-mediated excitotoxicity that in turn, contributes to 
neuronal injury (Lawrence et al. 1998; Stroemer & Rothwell 1998; Allan et al. 2000; Ye et al. 
2013), the contribution of glutamate signaling to enhanced dopamine neurotoxicity after the 
serial exposure to alcohol and Meth is unknown. 
 
A possible mechanism by which inflammation promotes glutamate-mediated excitotoxicity is 
through decreased glutamate uptake. Glutamate uptake occurs through glutamate 
transporter-1 (GLT-1, also known as excitatory amino acid transporter-2/EAAT2) on 
presynaptic terminals and astrocytes, and the glutamate aspartate transporter (GLAST, also 
known as excitatory amino acid transporter-1/EAAT1), located primarily on astrocytes (Chen 
et al., 2004; Roberts et al. 2014). Reductions in glutamate uptake are observed after chronic 
alcohol abuse which likely occurs through a decrease in transporter-mediated uptake 
(Kryger & Wilce 2010; Flatscher-Bader & Wilce 2008) or a functional reversal of transporter 
activity resulting in the increased availability of extracellular glutamate (Alhaddad et al. 2014) 
and activation of postsynaptic receptors to produce excitotoxicity.  
 
Excitotoxicity is also a consequence of increases in glutamate release. Meth causes acute 
increases in extracellular glutamate within the striatum (Mark et al. 2004; Nash & Yamamoto 
1992) to activate glutamate receptors and increase proteolysis of the cytoskeletal protein 
spectrin (Siman and Noszek,1988) that comprises nerve terminals in the striatum. 
Specifically, spectrin proteolysis from Meth-induced excitotoxicity contributes to dopamine 
terminal degradation in the striatum (Siman & Noszek 1988; Halpin et al. 2014; Staszewski & 
Yamamoto 2006; Tata & Yamamoto 2007).  Spectrin may be cleaved by caspase-3, a 
calcium-dependent protein that is activated by increases in calcium influx, into a breakdown 
product with a molecular weight of 120 kDa (Pike et al. 2001). Proteolysis by other calcium-
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activated proteases results in breakdown products of different molecular weights.  In rodent 
models of striatal dopamine loss after  1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) 
or 6-hydroxydopamine (6-OHDA) injections, the 120 kDa caspase-3 mediated spectrin 
breakdown products have been detected in the striatum prior to dopamine terminal loss 
(Grant et al. 2009) implicating it as a key contributor to dopaminergic damage.  However, It 
remains to be determined if spectrin proteolysis by caspase-3 occurs after the serial 
exposure to alcohol and Meth in a manner associated with increases in glutamate release 
and a reduction in glutamate transporters.  
 
The β-lactam antibiotic ceftriaxone (CEF) has been shown to be neuroprotective by 
increasing the expression and/or activity of the glutamate transporters in the brain (Rothstein 
et al. 2005; Wei et al. 2012).  It protects against excitotoxicity in rodent models of drug 
abuse, stroke, traumatic brain injury, Parkinson’s disease, and hypoxia (Goodrich et al. 
2013; Hameed et al. 2018; Cui et al. 2014; Barr et al. 2015; Lipski et al. 2007; Leung et al. 
2012; Jagadapillai et al. 2014). In addition, CEF has anti-inflammatory effects (Wei et al. 
2012) but it remains to be determined if it protects against the neurotoxic effects associated 
with the comorbidity of alcohol and Meth.  
 
The current study expands upon previous findings by Blaker and Yamamoto (2018) reporting 
a role for inflammation in the enhanced dopamine toxicity observed after the serial exposure 
to EtOH+Meth.  Because inflammation may promote glutamate-mediated excitotoxicity and 
contribute to neuronal damage after either drug alone, the current study investigated the role 
of glutamate signaling in mediating enhanced dopamine depletions after EtOH+Meth.  We 
tested the hypothesis that prior alcohol drinking decreases glutamate transporters and 
increases basal extracellular glutamate in a manner that exacerbates the acute increases in 
extracellular glutamate and excitotoxicity produced by Meth, as evidenced by breakdown of 
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the cytoskeletal protein spectrin and the associated neurotoxicity defined by the loss of 
dopamine content.  Furthermore, we predicted that the administration of the β-lactam 
antibiotic, CEF during alcohol drinking will prevent the excitotoxicity and the enhanced 
depletions of dopamine observed after the serial exposure to alcohol and Meth.  
 
Materials and Methods 
Animals 
Male Sprague Dawley rats (RRID:MGI:5651135; 175-199g; Envigo, Indianapolis, IN) were 
allowed one week to acclimate to the animal colony at Indiana University School of Medicine 
before beginning experiments.  Much of the previous work related to these experiments have 
used male rat models and therefore we used all males throughout experiments to expand 
upon previous findings.  Any identification of sex differences between males and females 
would require future studies.  All experiments were carried out and in accordance with the 
National Institutes of Health Guide for the Care and Use of Laboratory Animals and 
approved by the Indiana University Institutional Animal Care and Use Committee (Protocol 
#11042). This study was not pre-registered and no randomization was used to allocate 
animals to treatment groups.  
 
Drug Treatment 
The graphical timeline for all experiments can be viewed in Figure 1. After the initial 
acclimation period, rats were individually housed in order to accurately measure 10% 
ethanol (EtOH) intake per rat. As described in Blaker and Yamamoto (2018), rats were 
allowed access to two bottles of water or access to one bottle of 10% EtOH and a second 
bottle of water every other day for a total period of 28 days, and ad libitum access to food. 
On the days without EtOH access, a second water bottle was placed on the cage permitting 
A
cc
ep
te
d 
A
rt
ic
le
This article is protected by copyright. All rights reserved. 
access to two bottles at all times. Additionally, the placement of the EtOH bottle was altered 
upon each exposure as to prevent side bias.  
 
One day after the last day of EtOH drinking, rats were exposed to a binge injection regimen 
consisting of a total of 4 Meth (10 mg/kg) or saline injections, each injection 2 hours apart in 
the morning. (+) Methamphetamine-hydrochloride (Sigma, St. Louis, MO, cat #M-8750) was 
dissolved in 0.9% saline and control rats received injections of 0.9% saline (1 mL/kg) at the 
same time. This particular drug administration paradigm leads to comparable dopamine 
deficits observed in human brains (Callaghan et al. 2012; Volkow et al. 2001; McCann et al. 
1998). Additionally, the investigator-administered model permits control over the time course 
of injections and specific doses in order to clearly interpret the discrete pharmacological 
effects of Meth that are not feasible with a Meth self-administration paradigm.  
 
Body temperatures were measured every 30 minutes throughout the binge Meth regimen via 
subcutaneous temperature transponders (IPTT-300 transponder, BMDS) which were 
implanted one day prior to the binge Meth regimen.  All rats received temperature 
transponders, regardless of Meth or saline treatment.  
 
A subset of rats (n=76) received injections of the -lactam antibiotic ceftriaxone (Sigma cat 
#1098184; 200 mg/kg, ip) as described in Hu et al. (2015) once daily on days without EtOH 
access, to counter any decreases in glutamate transporters due to EtOH. Control rats 
received 0.9% saline injections (1 mL/kg). 
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Western Blotting 
Rats were rapidly decapitated without anesthetic 24 hr after the last day of EtOH access for 
GLAST and GLT-1 quantification, or 7 days after Meth for spectrin breakdown product (SBP) 
quantification. Striata were dissected, immediately frozen on dry ice, and homogenized in 
RIPA buffer for GLAST and GLT-1. Striatal tissue from rats euthanized at 7 days was 
dissected around the probe after microdialysis experiments and homogenized in a buffer 
comprised of 10 mM Tris, 10 mM EGTA, 250 mM sucrose, and HALT protease inhibitor 
cocktail (Thermo Scientific) as described in Halpin et al. (2014) for SBP analysis. Protein 
was quantified via Bradford assay. All samples for GLAST and GLT-1 quantification were 
reduced with 500 mM DTT (Fisher cat #PR-V3151) whereas those for spectrin were not. All 
samples for GLAST, GLT-1, and spectrin were diluted in Novex 4X LDS sample buffer 
(Invitrogen cat #NP0007) and 20 g or 30 g protein was loaded into each lane of 4-12% 
Bis-Tris gels (Invitrogen cat #NP0335) for GLAST/GLT-1 or spectrin, respectively, for SDS-
PAGE gel electrophoresis at 150V for 90 minutes. Proteins were transferred onto PVDF 
membrane for 2 hrs at 28V and then placed in 5% non-fat milk blocking buffer for 1 hr at 
room temperature. Membranes were incubated with primary antibody for the GLAST 
homolog EAAT1 (raised in rabbit; 1:1000, RRID:AB_304334; Abcam cat #ab416), guinea pig 
anti-GLT-1 (1:1000, RRID:AB_90949, Millipore cat #MAB1783), or mouse anti-non-erythroid 
α-spectrin (RRID:AB_94295, Millipore cat #MAB1622) for 18 hrs at 4C, washed with TBS 
containing 0.5% Tween, and incubated with horseradish peroxidase-conjugated secondary 
antibody (goat anti-rabbit IgG, 1:2500, RRID:AB_631748, Santa Cruz cat #SC2054; goat 
anti-guinea pig IgG, 1:3000, RRID:AB_650492, Santa Cruz cat #sc-2438; or anti-mouse IgG, 
1:2500, RRID:AB_2687626, Santa Cruz cat #SC516102) for 1 hr at room temperature. 
Membranes were washed again with 0.5% TBS-T, incubated with HyGLO-enhanced 
chemiluminescence and imaged with a FujiFilm LAS-4000 camera. Band density was 
acquired with Multi-Gauge V3.1 software and normalized against β-actin (1:3000, 
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RRID:AB_2223041, Millipore cat #MAB1501) or α-tubulin (1:2000, RRID:AB_477582, Sigma 
cat #T6074).  
 
In Vivo Microdialysis 
Microdialysis probes were constructed using 26 gauge stainless steel hypodermic tubing 
(Small Parts), PE 20 tubing (Becton Dickinson), silica tubing (150 m OD; Polymicro 
Technologies), 4 mm length hollow fiber microdialysis membrane (13kD molecular weight 
cutoff; 216 μm OD; Spectrum Laboratories, Rancho Dominguez, CA),  and tygon microbore 
tubing as described in Yamamoto and Pehek (1990). All junctions were glued with 
waterproof steel bond epoxy (Gorilla Glue) and allowed to cure before implantation.  
 
Intracranial surgery occurred immediately after removal of the EtOH bottle on the last day of 
drinking (Day 28).  Rats in all glutamate quantification experiments (including control groups) 
underwent intracranial surgery and microdialysis. Rats were anesthetized with a cocktail of 
ketamine (80 mg/kg) and xylazine (12 mg/kg) according to the IACUC protocol before 
undergoing stereotaxic surgery in the morning. Once fully anesthetized, the head was placed 
into a Kopf stereotaxic frame and the skull was exposed. According to Halpin et al. (2014), a 
hole was then drilled through the skull directly above the striatum [anteroposterior, +1.2; 
mediolateral (ML) 3.0; dorsoventral (DV), -6.5 mm].  A microdialysis probe was slowly 
lowered into the striatum and secured to the skull with cranioplastic cement over three 
stainless steel screws. Buprenorphine (0.05 mg/kg) was administered subcutaneously via 
short action preparation and 1% lidocaine was applied topically to minimize pain immediately 
after the surgery according to the IACUC protocol.  An additional injection of buprenorphine 
was administered 8-12 hrs after the surgery.  
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The following morning (day 29, 24 hrs after last day of EtOH or water drinking but prior to 
Meth or saline injections), artificial cerebrospinal fluid (aCSF) was infused with a Harvard 
Model 22 syringe infusion pump (Harvard Apparatus, Holliston, MA) at a flow rate of 1.5 
L/min through the microdialysis probe connected to a tether and single-channel swivel 
(Instech Laboratories, Plymouth Meeting, PA). After a 1.5 hr equilibration period, 3 baseline 
dialysate samples were collected, each 30 minutes apart. Directly after the third baseline 
collection, the first Meth or saline injection was administered. Dialysate samples were 
collected every 30 minutes throughout the binge saline or Meth regimen until 2 hrs after the 
last injection. Body temperatures were monitored continuously throughout the day. Probe 
placement was verified histologically after experiments.  
 
Glutamate recovery (%) of the probes was tested in vitro in test tubes containing aCSF and 
glutamate at 37 oC.  Perfusion flow rate was 1.5 µL/min and the difference between the 
known glutamate concentrations in vitro vs. the concentration of glutamate collected in the 
perfusate after 1 hr determined the relative recovery of glutamate for each probe.  
 
Extracellular Glutamate 
High-performance liquid chromatography (HPLC) with electrochemical detection was used to 
measure glutamate concentrations after o-pthaldialdehyde (OPA; Sigma cat #P0657) 
derivatization (Donzanti & Yamamoto 1988) in all rats that underwent microdialysis, including 
control groups. The stock derivatization reagent was made by dissolving 27 mg of OPA in 1 
mL of 100% methanol and mixed with 9 mL of 0.1M sodium tetraborate (pH 9.4) followed by 
the addition of 5 L -mercaptoethanol (BME). This stock solution was then diluted 1:3 with 
0.1 M sodium tetraborate buffer (pH 9.4) as described in Mark et al. (2007). Samples were 
loaded into an autosampler where 10 μL of the diluted stock derivatization reagent was 
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added to 20 μl of dialysate (or standard), mixed 3 times, and allowed to wait/react for 2 min 
before it was injected onto an OPA high-resolution column (150 x 4.6 mm; 5 µm particle 
size; Alltech). GLU was eluted using a mobile phase consisting of 0.1 M sodium phosphate 
and 0.1 mM EDTA in 10% methanol at pH 6.7. GLU was detected with an LC-4C 
amperometric detector (Bioanalytical Systems, Lafayette, IN) using a 6 mm glassy working 
electrode maintained at a potential of 0.6 V relative to an Ag/AgCl reference electrode. 
Glutamate content was analyzed via EZChrom ® software. Three baseline glutamate 
concentrations were averaged per rat to quantify basal glutamate in the striatum.  
 
Dopamine Content in Striatum 
Rats were rapidly decapitated without anesthetic 7 days after Meth and striata were 
dissected as described in Blaker and Yamamoto (2018). Briefly, tissue was sonicated in 0.25 
N perchloric acid and centrifuged for 20 min at a speed of 14,000 x g at 4°C. Supernatant 
was collected and injected onto a C18 column (250 x 4.6 mm, 5 µm particle diameter, 
Varian) for HPLC using a LC-4C amperometric detector (Bio-analytical Systems). The 
mobile phase consisted of 21 g/L citric acid, 10.65 g/L NaHPO4, 470 mg 1-octanesulfonic 
acid sodium salt (OSA), in 15% methanol at pH 4.0. Dopamine content was analyzed with 
EZChrom ® software. After complete removal of the supernatant, the remaining pellet was 
suspended in 1 N NaOH overnight at 4°C for protein quantification. The following day, 
protein content was determined via Bradford assay. Dopamine content (pg) from HPLC was 
normalized to total protein content (g) per rat.  
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Statistical Analyses 
Statistical analyses were performed using SigmaPlot V13.0 software for Windows (Systat 
Software). No exclusion criteria were pre-determined and therefore no animals were 
excluded from the study, i.e., the initial sample sizes are reflected in the total animals per 
group. Sample sizes are listed in Figure 1 as well as the results section.  Samples sizes in all 
experiments were calculated via an a priori sample size calculation with G*Power for 
Windows 10 software (Faul et al. 2007).  Differences in means previously reported from our 
lab (Blaker and Yamamoto, 2018; Mark et al. 2004) were used to determine p1 and p2 
values.  Specifically, the generic binomial test was chosen under the “exact” test family tab 
for differences between Meth alone and EtOH+Meth, and the a priori type of power analysis 
was selected. An alpha-value of 0.05, power of 0.80, p1 of 0.75 and p2 of 0.99 were used to 
calculate the sample sizes used throughout experiments.  Blinding was not conducted.  A 
one-way ANOVA was used to analyze the drinking behavior and t-tests were used to 
analyze glutamate transporters within the striatum, while the experiments including 
ceftriaxone were analyzed via two-way ANOVA within Meth-treated rats. Two-way repeated-
measures ANOVAs were used to analyze ethanol intake over time in ± CEF groups 
(between-subjects) and extracellular glutamate during Meth. Post-hoc Tukey tests were 
used for multiple comparisons.  All statistical analyses passed the Shapiro-Wilk normality 
test and Grubbs’ outlier test (no data points were excluded). The cutoff for statistical 
significance was α= 0.05 for all experiments.  
 
Results 
Rats voluntarily drink 10% EtOH over 28 days  
EtOH (or water control) was quantified in grams consumed per 24 hrs and normalized to 
body weight (kg) per rat. Rats consumed 2.17  0.35 g/kg on Day 1, 2.67  0.33 g/kg on Day 
7, 3.22  0.41 g/kg on Day 14, and 3.73  0.19 g/kg on Day 28. A repeated-measures 
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ANOVA showed that rats significantly increased EtOH intake over the 28 days (F (1, 68)=9.47, 
p=0.004; n = 72; Fig. 2).  Figure 2 contains EtOH drinking behavior for all rats regardless of 
intervention (or lack thereof).  
 
EtOH drinking decreases GLAST but not GLT-1 in the striatum  
GLAST and GLT-1 were quantified in the striatum 24 hrs after the last day of drinking. A 
decrease in GLAST (t(1,8)=3.71, p=0.006) but not GLT-1 (t(1,9)=0.18, p=0.86) was observed 
after EtOH compared to water (t-test, n = 4-7/group; Fig. 3A-B). Representative Western 
blots are shown in Fig. 3C.  
 
CEF during EtOH drinking does not affect EtOH intake  
To measure fluid intake between rats treated with CEF and those treated with saline vehicle 
(No CEF), bottles were weighed once per week in all groups (EtOH drinking with No CEF or 
CEF included in Figure 2). A repeated-measures 2-way ANOVA revealed a significant 
increase in EtOH over time in both CEF and No CEF groups but there were no differences 
between groups within each day (n = 24-49/group; Fig. 4A). Water intake did not change 
over time or between CEF and No CEF groups (Fig. 4B).  
 
EtOH-induced decreases in GLAST are prevented by CEF 
CEF (200 mg/kg) was administered to rats on the “EtOH off” days. 24 hrs after the last day 
of drinking, a 2-way ANOVA with Tukey post hoc analyses showed a significant interaction 
between EtOH and CEF (F (1,49) = 8.79, p<0.01) and that EtOH alone again decreased 
GLAST in the striatum compared to water groups (q=2.23, p=0.03). CEF treatment during 
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EtOH drinking protected against decreases in GLAST (Tukey post hoc, q=3.21, p=0.04 vs. 
EtOH+No CEF; n = 6-8/group; Fig. 5A). Representative Western blots are shown in Fig. 5B.  
 
Decreases in GLAST from EtOH exposure leads to increased basal glutamate in the 
striatum 24h after the last day of drinking 
Basal glutamate (µM) was quantified in the striatum 24 hrs after the last day of EtOH 
drinking by taking the mean of three baseline dialysate readings per rat and adjusting for 
average % glutamate recovery (21.3 ± 0.96%) of the probe.  A 2-way ANOVA showed a 
significant interaction between EtOH and CEF (F (1, 49)=9.87, p=0.003) and Tukey post hoc 
analyses revealed a significant increase in basal glutamate in rats that drank EtOH 
compared to rats that did not drink EtOH (EtOH+No CEF vs. Water+No CEF, q=8.86, 
p<0.001). CEF did not affect basal glutamate in water-only drinking rats (Water+CEF vs. 
Water+No CEF, p=0.78) but attenuated the increases in basal glutamate produced by EtOH 
drinking (EtOH+CEF vs. EtOH+No CEF; q=5.73, p<0.001; n = 12-16/group; Fig. 6).   
 
Previous EtOH drinking enhances Meth-induced increases in extracellular glutamate in the 
striatum  
A three-way ANOVA with EtOH, Meth, and time as factors revealed significant interactions 
between EtOH and Meth (F (1, 437)=36.63, p<0.001) and between Meth and time (F (18, 
437)=37.38, p<0.001). Tukey post hoc analysis showed that Meth significantly increased 
extracellular glutamate (q=42.77, p<0.001 vs. saline control groups) and the increase was 
enhanced by prior EtOH drinking (EtOH+Meth vs. Water+Meth; q=12.83, p<0.001; n = 6-
12/group; Fig. 7A).   
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There were no differences in EtOH vs. Water rats with regard to body temperature 
throughout Meth injections (average over time: 40.26 ± 0.61 ºC and 40.72 ± 0.44 ºC, 
respectively).  
 
A subset of rats was treated with CEF during EtOH drinking, and CEF alone did not affect 
extracellular glutamate throughout the day of microdialysis (vs. Water+No CEF+Saline; data 
not shown). Analysis of cumulative glutamate concentrations via a two-way ANOVA within 
Meth-treated rats using EtOH and CEF as factors revealed a significant main effect of EtOH 
(F (1,25) = 5.26, p<0.05) and a significant increase in Meth-treated rats that drank EtOH vs. 
Water (q=4.20, p<0.01). Tukey post hoc analyses showed that rats that received CEF during 
EtOH had comparable cumulative glutamate concentrations to the Meth alone group 
(represented as EtOH+CEF vs. Water+CEF) and CEF protected against the enhanced 
increases in glutamate (Tukey post hoc vs. EtOH+No CEF, q=4.204, p<0.05) (n = 6-
10/group; Fig. 7B). CEF treatment did not affect Meth-induced hyperthermia compared to 
vehicle-treated (No CEF) controls (average over time: 39.98 ± 0.72 ºC and 40.21 ± 0.49 ºC, 
respectively).  
 
Serial exposure to EtOH and Meth leads to caspase-3 mediated spectrin breakdown in the 
striatum 7 days after Meth  
SBPs were measured in the striatum 7 days after Meth. Neither EtOH nor Meth alone 
increased caspase-3 mediated spectrin breakdown (data not shown), but a 2-way ANOVA 
with Tukey post hoc analyses within Meth-treated rats revealed a significant increase in 
SBPs at 120 kDa in rats that drank EtOH compared to Water drinking rats (i.e., 
EtOH+Meth+No CEF vs. Water+Meth+No CEF; q=5.27, p=0.002, Fig. 8A). CEF during 
EtOH (EtOH+CEF+Meth) blocked this effect (q=4.72, p=0.03 vs. EtOH++NoCEF+Meth; n = 
6-10/group; Fig. 8A). A representative Western blot for all treatment groups is shown in Fig. 
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8B.  A band at 145 kDa is also visible on the Western blot for SBPs, and this represents a 
SBP proteolyzed by a different protease known as calpain as described in Halpin et al. 
(2014).  The calpain-mediated SBP bands were also analyzed and no differences were 
detected between groups (data not shown).  
 
CEF administration during EtOH drinking attenuates enhanced dopamine depletions 7 days 
after Meth 
Striatal dopamine concentrations were quantified at 7 days after Meth. A two-way ANOVA 
using EtOH and Meth as factors revealed that rats exposed to Meth displayed significantly 
less striatal dopamine (62.13 ± 3.80 pg/µg protein) compared to all saline controls after 7 
days (including water and EtOH drinkers; 108.85 ± 2.91 pg/µg protein; data not shown; F (1, 
33)=8.97, p=0.03, n = 7-8/group). Within the Meth-treated rats, a 2-way ANOVA showed a 
significant interaction between EtOH and CEF (n = 6-10/group; F (1, 27)=9.78, p=0.004). 
Tukey post hoc analyses revealed that Meth-treated rats previously exposed to EtOH 
displayed enhanced dopamine depletions compared to Water groups (i.e., EtOH+No 
CEF+Meth vs. Water+No CEF+Meth; q=8.73, p<0.001) and this was attenuated by CEF 
during EtOH (EtOH+No CEF+Meth vs. EtOH+CEF+Meth; q=5.34, p<0.001 vs. EtOH+No 
CEF within Meth groups; n = 6-10/group; Fig. 9).  
 
Discussion 
 
Intermittent access to EtOH over 28 days decreased GLAST immunoreactivity in the 
striatum and increased basal glutamate concentrations when measured 24 hrs after the last 
day of drinking. Prior EtOH drinking enhanced and synergized with the Meth-induced 
increases in extracellular glutamate within the striatum, spectrin proteolysis, and long-lasting 
depletions of dopamine. The β-lactam antibiotic CEF during the intermittent withdrawal days 
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from EtOH drinking protected against the decreases in GLAST and the exacerbated 
increases in extracellular glutamate produced by Meth. CEF also attenuated the breakdown 
of spectrin and the enhanced dopamine depletions 7 days after EtOH+Meth.  
 
Rats increased EtOH intake over 28 days (Fig. 2) and despite consuming lower amounts 
than we have published (Blaker & Yamamoto, 2018), EtOH drinking resulted in decreased 
GLAST in the striatum at 24 hrs. In contrast, GLT-1 was unaffected by EtOH drinking (Fig. 
3).  The lack of changes in GLT-1 differs from the findings using alcohol-preferring rat strains 
(Rao & Sari 2012) however, others have reported no effect on GLT-1 after EtOH (Devaud 
2001) despite a decrease in glutamate uptake (Melendez et al. 2005).  These findings 
suggest other glutamate transporters (e.g. GLAST) are involved as evidenced by the current 
findings of a decrease in GLAST after voluntary EtOH drinking (Fig. 3). The mechanism by 
which EtOH drinking decreases GLAST is unknown, but could be due to inflammation. It has 
been shown that 28 days of intermittent access to EtOH increases pro-inflammatory 
cytokines as well as lipopolysaccharide (LPS) and COX-2 (Blaker & Yamamoto 2018). 
Cytokines such as tumor necrosis factor-α (TNF-α) and interleukin-1β (IL-1β) decrease 
GLAST mRNA and protein, respectively (Dumont et al. 2014; Mandolesi et al. 2013) and 
could link EtOH drinking with decreases in GLAST.  
 
The decreases in GLAST were blocked by CEF pre-treatment during EtOH drinking (Fig. 5) 
and could be mediated by the anti-inflammatory properties of CEF. Wei et al. (2012) showed 
that CEF blocks increases in TNF-α, IL-1β, and interferon-γ associated with traumatic brain 
injury in rats. Thus, EtOH-induced changes in glutamate neurotransmission may be closely 
associated with increases in inflammation. Regardless, the current findings provide new 
evidence for the ability of CEF to block decreases in GLAST after EtOH without altering 
GLAST under normal conditions in the water-drinking rats (Fig. 5). This is consistent with 
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previous studies reporting no change in GLAST or EAAC1 after CEF in naïve animals 
(Rothstein et al. 2005; Lee et al. 2008).  
 
No changes in EtOH or water drinking were produced by CEF (Fig. 4A) and differ from the 
reports by Alhaddad et al. (2014) and Das et al. (2015).  These differences could be due to 
rat strain differences as Sprague Dawley rats were used in the current study and not alcohol 
preferring rats (Alhaddad et al. 2014; Das et al. 2015). Additionally, we administered CEF 
during the intermittent “EtOH off” days and therefore, CEF was not present during actual 
EtOH drinking. Regardless, the effects of CEF on the supra-additive effects of Meth-induced 
increases in glutamate, spectrin proteolysis and decreases in dopamine content of EtOH 
exposed rats were not due to alterations in prior EtOH intake. 
 
Glutamate transporter expression could be regulated by calcium-calmodulin-dependent 
protein kinase II (CaMKII) which specifically, targets GLAST/EAAT1 but not EAAT2 (Chawla 
et al. 2017). Autophosphorylation of CaMKII has recently been associated with alcohol 
dependence (Easton et al. 2013), and its autophosphorylation leads to phosphorylation of 
the N-methyl-D-aspartate (NMDA) receptor to promote its activation and contribute to 
excitotoxicity (Kitamura et al. 1993; McGlade-McCulloh et al. 1993). Similarly, CaMKII is 
altered after Meth application in vitro (Chen et al. 2016) and is required for Meth-induced 
increases in intracellular calcium (Goodwin et al. 2009).  
 
The decrease in GLAST after the last day of EtOH drinking could be responsible for the 
increase in basal glutamate within the striatum of EtOH drinking compared to water drinking 
only rats (Fig. 6). To address this relationship, basal glutamate was quantified after CEF 
treatment during EtOH drinking. Glutamate concentrations in water drinking control groups 
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are comparable to other studies published in rodents (Griffin et al. 2015; Pati et al. 2016). 
Similar to the prevention of EtOH-induced decreases in GLAST, CEF also prevented the 
increases in basal glutamate after EtOH drinking (Fig. 6) and further supports the role of 
decreases in GLAST in mediating the increased basal levels of glutamate produced by 
EtOH. It remains to be determined if other glutamate transporters such as the cysteine-
glutamate antiporter (xCT) located on astrocytes (Ottestad-Hansen et al. 2018; Pow 2001) 
are affected by EtOH drinking. The increases in glutamate observed in our study could be 
due to the combined effects of the reversed action of xCT to release glutamate from 
astrocytes (Ding et al. 2013; Lewerenz et al. 2013) in conjunction with the decrease in 
glutamate uptake by GLAST.  
 
The increased glutamatergic state of EtOH-drinking rats was enhanced upon Meth exposure 
compared to Meth-treated rats that drank water only (Fig. 7). The finding that Meth alone 
acutely increased the extracellular concentrations of glutamate is consistent with previous 
studies (Nash & Yamamoto 1992). It should be noted that the increases in glutamate do not 
occur immediately after the 1st injection of Meth.  This somewhat delayed increase may be 
due to the combined effects of release through polysynaptic mechanisms (Mark et al., 2004) 
and reduced uptake, the latter affected by prior EtOH exposure (Fig. 5) leading to a more 
rapid and enhanced accumulation of extracellular glutamate (Fig. 7A). Moreover, the 
enhanced increase in glutamate in rats exposed to EtOH+Meth was blocked by CEF during 
EtOH drinking.  This evidence in conjunction with the finding that CEF blocked the decrease 
in GLAST observed after EtOH drinking supports the role of EtOH-induced GLAST changes 
in mediating the enhanced extracellular glutamate effects observed after the serial exposure 
to EtOH and Meth.   
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One potential limitation of these studies is the use of ketamine as an anesthetic. Ketamine is 
a NMDA receptor antagonist and may therefore affect glutamate signaling in the brain (Orser 
et al., 1997). However, ketamine was administered during surgery after EtOH drinking had 
ended and before Meth injections began. Therefore, ketamine should be completely 
excreted from the system prior to any drug administration and should not affect Meth-
induced excitotoxicity. Furthermore, all treatment groups underwent ketamine administration 
and intracranial surgery and therefore the proper controls were employed for any potential 
effects of ketamine alone.   
 
The appearance of spectrin breakdown in EtOH+Meth rats (Fig. 8) is consistent with 
previous findings of excitotoxicity (Staszewski & Yamamoto 2006; Halpin et al. 2014; Tata & 
Yamamoto 2007) and can be explained by increases in extracellular glutamate resulting 
from decreased uptake and/or increased release (Figs. 5 and 7).  Moreover, increases in 
glutamate are known  to activate cysteine proteases such as calpain and caspase-3 (Wang 
et al. 1998) that cause proteolysis.  More specifically, caspase-3 causes the proteolysis of 
the presynaptic cytoskeletal protein, spectrin localized to neurons (Goodman et al. 1995; 
Riederer et al. 1986). The proteolytic cleavage of spectrin results in breakdown products of 
different molecular weights and in the case of caspase-3 activation, causes the cleavage of 
spectrin into a 120 kDa breakdown product (Pike et al. 2001).  The finding that the serial 
exposure to EtOH drinking and Meth-induced increases in the appearance of a 120 kDa 
spectrin breakdown product suggests caspase-3 mediated spectrin proteolysis as a 
consequence of the co-exposure to EtOH and Meth and a contributor to the synergistic 
effects of EtOH and Meth on striatal dopamine depletions (Blaker & Yamamoto 2018). 
Although we did not observe caspase-3-mediated proteolysis with either EtOH drinking 
alone or Meth alone, EtOH-induced neuron death and acute Meth-induced spectrin 
proteolysis have previously been observed (Warren et al. 2005; Warren et al. 2007; 
Staszewski & Yamamoto 2006; Halpin et al. 2014).  One potential limitation of these 
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experiments is that spectrin breakdown products were quantified in tissue dissected from 
around the probe tract after intracranial surgery.  However, all rats (controls included) 
received intracranial surgery and probe implantation, and therefore it is unlikely that the 
increase in spectrin breakdown produced by EtOH+Meth vs controls is due to damage from 
probe implantation in the striatum.  
 
The synergistic depletions of dopamine content after the serial exposure to EtOH drinking 
and Meth injections can be explained by different mechanisms of glutamatergic activation.  
EtOH drinking alone decreased GLAST and increased the basal extracellular concentration 
of glutamate, presumably through the reduced uptake by astrocytes.  GLT-1 was not 
affected by EtOH drinking and indicates a preference for degradation of astrocytic glutamate 
transporters rather than those on presynaptic neuron terminals.  In contrast, current and 
previous studies  showed Meth injections into rats naïve to EtOH cause acute increases in 
glutamate through polysynaptic mechanisms and the reversal of transporter (non-GLAST) 
activity (Mark et al. 2004; Halpin et al. 2014). Future studies are required, but these data 
suggest that the different mechanisms by which EtOH and Meth increase glutamate 
transmission can synergize to produce a supra-additive long-term depletion of dopamine 
content in the striatum that is attenuated but not blocked by the action of CEF on GLAST 
(Fig. 9).   
 
Overall, the current study provides a novel role for decreased glutamate uptake induced by 
EtOH drinking to promote an enhanced neurotoxicity to the subsequent exposure to Meth 
and provides a new dimension to the co-morbidity associated with the frequent co-abuse of 
these drugs.   
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Figure Legends  
 
Fig. 1 Timeline of experiments. EtOH-drinking and water-control rats went through 2-bottle 
choice drinking paradigm for 28 days. Groups A and B did not receive any injections during 
the drinking paradigm while Groups C and D received saline or CEF injections on days 
without EtOH access. Groups A and C were euthanized 24 hrs after the last day of drinking 
(day 29) to measure GLAST and GLT-1 in the striatum. Groups B & D received probe 
implantation intracranially after the last EtOH exposure on Day 28, followed by Meth or 
saline injections on Day 29 during microdialysis to quantify extracellular glutamate. 7 days 
after Meth or saline, Groups B & D were euthanized and striata were dissected to measure 
spectrin breakdown products and dopamine content.  
 
Fig. 2. Drinking behavior in Sprague Dawley rats over 28 days. Rats increased intake of 10% 
EtOH (g/kg/24 hrs) over time (*p < 0.01; n = 72). “n” indicates number of animals included. 
The thicker line in each box represents the mean of the group.  
 
Fig. 3. EtOH drinking decreases striatal GLAST but not GLT-1. A) No changes were 
observed in GLT-1 immunoreactivity after EtOH compared to Water. B) GLAST 
immunoreactivity was decreased in the striatum 24 hrs after the last day of EtOH compared 
to Water (*p < 0.01). n = 4-7/group. “n” indicates number of animals included. C) 
Representative Western blots for GLAST, GLT-1, and the control β-actin are provided.  
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Fig. 4. CEF during EtOH drinking does not affect EtOH intake nor water intake. A) EtOH 
intake and B) water intake were not affected by CEF administration on the “EtOH off” days (p 
> 0.05). n = 24-49/group. The thicker line in each box represents the mean of the group.   
 
Fig. 5. Ceftriaxone during EtOH drinking blocks decreases in GLAST. A) EtOH drinking 
decreased GLAST in the striatum at 24 hrs after the last day of EtOH drinking (*p < 0.05 vs. 
Water+No CEF) and this was blocked by CEF treatment during drinking (EtOH+CEF vs. 
EtOH+No CEF; #p <0.05; n = 6-8/group). “n” indicates number of animals included. B) 
Representative Western blots for GLAST and β-actin are provided for all treatment groups.  
 
Fig. 6. EtOH drinking increases basal glutamate in the striatum. Extracellular glutamate was 
significantly increased in the striatum 24 hrs after the last day of EtOH (*p < 0.001 vs. 
Water+SalineNo CEF). The EtOH-induced increases in glutamate were attenuated by CEF 
treatment during drinking (#p < 0.001 vs. EtOH+No CEF). n = 12-16/group. “n” indicates 
number of animals included. 
 
Fig. 7. Previous EtOH exposure enhances Meth-induced increases in striatal glutamate. A) 
Meth significantly increased glutamate in the striatum over the time course of four injections 
(*p < 0.001 vs. all saline vehicle groups) and this was further enhanced in rats previously 
exposed to EtOH (**p < 0.001 vs. Water+Meth; n = 6-12/group). Arrows denote injection 
time. B) Within Meth-treated rats, EtOH rats had significantly higher glutamate content 
(cumulative % increase compared to baseline) in the striatum compared to Water rats (&p < 
0.01). This was attenuated by CEF administration during EtOH drinking (#p < 0.05 vs. 
EtOH+No CEF; n = 6-10/group). “n” indicates number of animals included. The dotted line 
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represents the amount of cumulative % change of glutamate from baseline in the striatum of 
Water+No CEF+Saline rats over time (2182.43 ± 22.98).  
 
Fig. 8. EtOH+Meth induce caspase-mediated spectrin proteolysis in the striatum 7 days after 
Meth. Neither EtOH or Meth alone affected spectrin breakdown products (SBPs) 7 days after 
Meth, but within Meth-treated rats, EtOH+No CEF+Meth rats displayed increased SBPs in 
the striatum vs. Water+No CEF+Meth (*p < 0.05). EtOH+CEF prevented spectrin proteolysis 
(#p < 0.05; EtOH+CEF+Meth vs. EtOH+No CEF+Meth). n = 6-10/group. “n” indicates 
number of animals included. The dotted line represents the average Water+No CEF+Saline 
control group (100 ± 7.21% Water+No CEF+Saline).  
 
Fig. 9. CEF during EtOH drinking attenuates the enhanced dopamine depletions observed 7 
days after Meth. Meth significantly depleted dopamine in the striatum (&p < 0.05 vs. saline 
groups represented by gray bar). Dopamine was further depleted in Meth-treated rats 
previously exposed to EtOH (*p < 0.001 vs. Water+Meth groups) and CEF attenuated this 
synergistic effect (#p < 0.001 vs. EtOH+No CEF; n = 6-10/group). “n” indicates number of 
animals included. The gray bar represents the mean striatal dopamine content + SEM of 
saline control rats (108.85 ± 2.92 pg/µg total protein).  
  
A
cc
ep
te
d 
A
rt
ic
le
This article is protected by copyright. All rights reserved. 
 
  
A
cc
ep
te
d 
A
rt
ic
le
This article is protected by copyright. All rights reserved. 
 
  
A
cc
ep
te
d 
A
rt
ic
le
This article is protected by copyright. All rights reserved. 
 
  
A
cc
ep
te
d 
A
rt
ic
le
This article is protected by copyright. All rights reserved. 
 
  
A
cc
ep
te
d 
A
rt
ic
le
This article is protected by copyright. All rights reserved. 
 
  
A
cc
ep
te
d 
A
rt
ic
le
This article is protected by copyright. All rights reserved. 
 
  
A
cc
ep
te
d 
A
rt
ic
le
This article is protected by copyright. All rights reserved. 
 
  
A
cc
ep
te
d 
A
rt
ic
le
This article is protected by copyright. All rights reserved. 
 
  
A
cc
ep
te
d 
A
rt
ic
le
This article is protected by copyright. All rights reserved. 
 
